These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
580 related articles for article (PubMed ID: 19904283)
1. Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks. Semple BD; Kossmann T; Morganti-Kossmann MC J Cereb Blood Flow Metab; 2010 Mar; 30(3):459-73. PubMed ID: 19904283 [TBL] [Abstract][Full Text] [Related]
2. Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events. Gouwy M; Struyf S; Noppen S; Schutyser E; Springael JY; Parmentier M; Proost P; Van Damme J Mol Pharmacol; 2008 Aug; 74(2):485-95. PubMed ID: 18469140 [TBL] [Abstract][Full Text] [Related]
3. Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2. Ringe J; Strassburg S; Neumann K; Endres M; Notter M; Burmester GR; Kaps C; Sittinger M J Cell Biochem; 2007 May; 101(1):135-46. PubMed ID: 17295203 [TBL] [Abstract][Full Text] [Related]
4. Combinatorial model of chemokine involvement in glomerular monocyte recruitment: role of CXC chemokine receptor 2 in infiltration during nephrotoxic nephritis. Zernecke A; Weber KS; Erwig LP; Kluth DC; Schröppel B; Rees AJ; Weber C J Immunol; 2001 May; 166(9):5755-62. PubMed ID: 11313419 [TBL] [Abstract][Full Text] [Related]
5. Chronic expression of monocyte chemoattractant protein-1 in the central nervous system causes delayed encephalopathy and impaired microglial function in mice. Huang D; Wujek J; Kidd G; He TT; Cardona A; Sasse ME; Stein EJ; Kish J; Tani M; Charo IF; Proudfoot AE; Rollins BJ; Handel T; Ransohoff RM FASEB J; 2005 May; 19(7):761-72. PubMed ID: 15857890 [TBL] [Abstract][Full Text] [Related]
6. Short-Term Exercise Training Alters Leukocyte Chemokine Receptors in Obese Adults. Barry JC; Simtchouk S; Durrer C; Jung ME; Little JP Med Sci Sports Exerc; 2017 Aug; 49(8):1631-1640. PubMed ID: 28319586 [TBL] [Abstract][Full Text] [Related]
7. Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases. Bose S; Cho J Arch Pharm Res; 2013 Sep; 36(9):1039-50. PubMed ID: 23771498 [TBL] [Abstract][Full Text] [Related]
8. CC chemokine ligand 2 and CXC chemokine ligand 8 as neutrophil chemoattractant factors in canine idiopathic polyarthritis. Murakami K; Maeda S; Yonezawa T; Matsuki N Vet Immunol Immunopathol; 2016 Dec; 182():52-58. PubMed ID: 27863550 [TBL] [Abstract][Full Text] [Related]
9. Chemokines and their receptors in the central nervous system. Bajetto A; Bonavia R; Barbero S; Florio T; Schettini G Front Neuroendocrinol; 2001 Jul; 22(3):147-84. PubMed ID: 11456467 [TBL] [Abstract][Full Text] [Related]
10. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. Babcock AA; Kuziel WA; Rivest S; Owens T J Neurosci; 2003 Aug; 23(21):7922-30. PubMed ID: 12944523 [TBL] [Abstract][Full Text] [Related]
11. CCL2/CCR2 signaling in cancer pathogenesis. Hao Q; Vadgama JV; Wang P Cell Commun Signal; 2020 May; 18(1):82. PubMed ID: 32471499 [TBL] [Abstract][Full Text] [Related]
12. CCL2, but not its receptor, is essential to restrict immune privileged central nervous system-invasion of Japanese encephalitis virus via regulating accumulation of CD11b(+) Ly-6C(hi) monocytes. Kim JH; Patil AM; Choi JY; Kim SB; Uyangaa E; Hossain FM; Park SY; Lee JH; Kim K; Eo SK Immunology; 2016 Oct; 149(2):186-203. PubMed ID: 27260136 [TBL] [Abstract][Full Text] [Related]
13. Targeting the CCL2-CCR2 axis in depressive disorders. Curzytek K; Leśkiewicz M Pharmacol Rep; 2021 Aug; 73(4):1052-1062. PubMed ID: 34031863 [TBL] [Abstract][Full Text] [Related]
15. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets. Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472 [TBL] [Abstract][Full Text] [Related]
16. In Vivo Models to Study Chemokine Biology. Amaral FA; Boff D; Teixeira MM Methods Enzymol; 2016; 570():261-80. PubMed ID: 26921950 [TBL] [Abstract][Full Text] [Related]
17. A protective role for ELR+ chemokines during acute viral encephalomyelitis. Hosking MP; Liu L; Ransohoff RM; Lane TE PLoS Pathog; 2009 Nov; 5(11):e1000648. PubMed ID: 19893623 [TBL] [Abstract][Full Text] [Related]
18. Role of astrocytes and chemokine systems in acute TNFalpha induced demyelinating syndrome: CCR2-dependent signals promote astrocyte activation and survival via NF-kappaB and Akt. Quinones MP; Kalkonde Y; Estrada CA; Jimenez F; Ramirez R; Mahimainathan L; Mummidi S; Choudhury GG; Martinez H; Adams L; Mack M; Reddick RL; Maffi S; Haralambous S; Probert L; Ahuja SK; Ahuja SS Mol Cell Neurosci; 2008 Jan; 37(1):96-109. PubMed ID: 17949991 [TBL] [Abstract][Full Text] [Related]
19. Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue. Simpson J; Rezaie P; Newcombe J; Cuzner ML; Male D; Woodroofe MN J Neuroimmunol; 2000 Aug; 108(1-2):192-200. PubMed ID: 10900353 [TBL] [Abstract][Full Text] [Related]
20. CXCL8 as a Potential Therapeutic Target for HIV-Associated Neurocognitive Disorders. Mamik MK; Ghorpade A Curr Drug Targets; 2016; 17(1):111-21. PubMed ID: 26112047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]